MMTI News

Image
Grand MMTI

2016

October 4, 2016: Grand MMTI Translational Lab Director, Arun Wiita, receives highly competitive NIH New Innovator Award

September 27, 2016: Novel myeloma treatment developed in the lab of Grand MMTI researcher Bin Liu licensed to Fortis Therapeutics

2015

December 18, 2015: Grand MMTI Researcher, James Wells, Elected to the National Academy of Inventors

July 21, 2015: Grand MMTI Researcher, Elad Ziv, Part of Team Identifying Genetic Variation Linked to Poor Survival in Multiple Myeloma Patients

June 19 2015: Grand MMTI Contributes to and Participates in the MMRF coMMpass Study to Identify the Genetic Changes with Myeloma Initiation and Progression

April 22, 2015:  Grand MMTI Researcher, James Wells, Elected to American Academy of Arts and Sciences' 2015 Class


2014

Thomas MartinDecember 7, 2014: ASH 2014 Coverage: Monoclonal Antibodies and Combination Therapies Showing Promise [Video]

 

UCSF CancerSeptember 8, 2014:  Grand MMTI Researcher, Peter Walter, Receives Prestigious Lasker Award

June 10, 2014: Myeloma Research Progress: Anti-CD38 Monoclonal Antibodies in Development [Video]

June 3, 2014: Anti-CD38 Antibody Generates Excitement in Multiple Myeloma

 

 

2013

 

UCSF Cancer Dec 12, 2013:  Multiple Myeloma Research Foundation (MMRF) Recognizes Outstanding Partners in Academia and Industry

July 18, 2013: Deadliest Cancers May Respond to New Drug Treatment Strategy

April 3, 2013: Grand MMTI Fellow, Dr. Michael Pourdehnad, awarded the 2013 AACR-Millennium Fellowship in Lymphoma Cancer Research to advance his work on determining the role of oncogenic translational factors in multiple myeloma drug-resistance.

2012

June 14, 2012: Cancer’s Next Magic Bullet May Be Magic Shotgun

April 15, 2012: AACR Inducts Frank McCormick, PhD, FRS, DSc (hon) as President

April 2, 2012: UCSF’s Frank McCormick now leads world’s largest cancer research association

February 22, 2012: Cancer Research Shows Promise of New Drugs

 

2011

December 23, 2011: A cancer drug company founded by UCSF Professor Kevan Shokat, PhD, has been acquired for $190 million

December 22, 2011: Peter Walter Awarded €100,000 Paul Ehrlich and Ludwig Darmstaedter Prize in 2012 for Uncovering How Cells Cope with Stress

September 27, 2011: Peter Walter Awarded Otto Warburg Medal

April 20, 2011: Kevan Shokat Elected to American Academy of Arts and Sciences

March 30, 2011: James Wells receives the Bristol-Myers Squibb Smissman Awards

March 22, 2011: AACR Names Frank McCormick New President-Elect

 

2010

July 29, 2010: Frank McCormick is Honored by the American Society of Clinical Oncology

July 19, 2010: UCSF Spinoff Calithera Shows Promise of Translational Research

July 7, 2010: Mission Bay Capital invests in UCSF cancer therapy spinoff with technology licensed from the laboratory of Jim Wells

June 9, 2010: A One-Stop Shop for Myeloma Research

April 9, 2010: Wells wins ASBMB-Merck Award

March 16, 2010: Blocking Cancer in its Path: New Cellular Defect Discovered

 

2009

July 2009: $2M Gift from Grands Launches Multiple Myeloma Initiative

May 1, 2009: Kevan Shokat elected to National Academy of Sciences

April 8, 2009: Peter Walter Wins Gaidner International Award